Gene defects and mutant ALK kinase in human solid tumors

Details for Australian Patent Application No. 2012201154 (hide)

Owner Cell Signaling Technology, Inc.

Inventors Rikova, Klarisa; Haack, Herbert; Sullivan, Laura; Gu, Ting-Lei; Possemato, Anthony; Guo, Ailan; Macneil, Joan; Yu, Jian

Agent Houlihan2

Pub. Number AU-B-2012201154

Parent 2007351581

Filing date 28 February 2012

Wipo publication date 22 March 2012

Acceptance publication date 13 September 2012

International Classifications

C07H 21/02 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 38/00 Medicinal preparations containing peptides

C07K 1/00 General processes for the preparation of peptides

C07K 16/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12Q 1/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

15 March 2012 Complete Application Filed

22 March 2012 Application Open to Public Inspection

  Published as AU-B-2012201154

13 September 2012 Application Accepted

  Published as AU-B-2012201154

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012201155-Multi power sourced electric vehicle

2012201153-Strap winder